Summit Securities Group’s GSK GSK Stock Holding History

Summit Securities Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,100	Closed	-$427K	–	695
2024 Q2	$427K	Buy	+11,100	New	+$467K	0.08%	113
2022 Q2	–	Sell	-24,800	Closed	-$1.35M	–	1069
2022 Q1	$1.35M	Buy	24,800 +21,200	+589%	+$1.15M	0.15%	113
2021 Q4	$198K	Buy	3,600 +3,541	+6,002%	+$184K	0.01%	601
2021 Q3	$283K	Buy	+59	New	+$2.96K	0.02%	537
2021 Q1	–	Sell	-80	Closed	-$368K	–	657
2020 Q4	$368K	Hold	80	–	–	0.03%	416
2020 Q3	$376K	Buy	+80	New	+$4.01K	0.04%	252
2019 Q2	–	Sell	-43	Closed	-$226K	–	350
2019 Q1	$226K	Buy	+43	New	+$2.15K	0.04%	176
2017 Q2	–	Sell	-42	Closed	-$223K	–	299
2017 Q1	$223K	Buy	+42	New	+$2.13K	0.06%	263
2015 Q4	–	Sell	-18	Closed	-$8K	–	347
2015 Q3	$8K	Buy	+18	New	+$937	0.01%	265

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Summit Securities Group's GSK Position: Q1 2026 in Review

Summit Securities Group reduced its GSK (GSK) stake by 86% in Q1 2026, selling an estimated $103K and leaving 300 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #555.

Summit Securities Group first reported a position in GSK in Q2 2013 and has held it in 36 quarters since. The position peaked at $1.97M in Q4 2019. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Summit Securities Group held 300 shares of GSK worth $16.6K as of Q1 2026.
Summit Securities Group sold 1,900 GSK shares in Q1 2026, an estimated $103K.
GSK made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #555 holding.
Summit Securities Group first reported a position in GSK in Q2 2013 and has held it in 36 quarters since.
Summit Securities Group's GSK position peaked at $1.97M in Q4 2019.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.